The Clinical Pharmacology of ImipramineImplications for Therapeutics
Alexander H. Glassman, MD;
James M. Perel, PhD
Arch Gen Psychiatry. 1973;28(5):649-653.
Abstract
In the last several years it has become apparent that identical oral doses of a tricyclic antidepressant can, in different individuals, result in radically different blood levels. This phenomenon which is the result of drug-drug interactions and individual genetic characteristics has major clinical implications. The plasma level resulting from a standard oral dose can be markedly increased or decreased by the concomitant administration of numerous usually used medications. This is a significant and commonly unrecognized problem and compounds the genetic metabolic variability inherent in these drugs.
In this review imipramine hydrochloride is used as a model for the tricyclic antidepressants in general. Its metabolism and pharmacodynamics are examined with specific emphasis on their relationship to the marked individual variability seen in this class of drugs and the relationship of this variability to clinical effectiveness.
Author Affiliations
New York
From the New York State Psychiatric Institute and the Department of Psychiatry, Columbia University, College of Physicians and Surgeons, New York.
Footnotes
Accepted for publication Jan 10, 1973.
Reprint requests to the New York State Psychiatric Institute, 722 W 168th St, New York, NY 10032 (Dr. Glassman).
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Withdrawal From Long-term High-Dose Desipramine Therapy: Clinical and Biological Changes
Brown et al.
Arch Gen Psychiatry 1978;35:1261-1264.
ABSTRACT
Clinical Implications of Imipramine Plasma Levels for Depressive Illness
Glassman et al.
Arch Gen Psychiatry 1977;34:197-204.
ABSTRACT
|
